# Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate

> **NCT02901106** · PHASE4 · TERMINATED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 11 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Dimethyl fumarate

## Key facts

- **NCT ID:** NCT02901106
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-23
- **Primary completion:** 2017-10-17
- **Final completion:** 2017-10-17
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Another surveillance protocol was initiated by the OFSEP (OFSEP cohort) which allows to follow all the patients, whatever their treatment.
- **Last updated:** 2019-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901106, "Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02901106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*